Aggregator
Scientists find a bone-building switch that could fight osteoporosis
An experimental compound called AP503 significantly strengthened bones in mice by activating GPR133, a receptor that boosts bone formation while slowing bone loss. Because the same treatment has also been linked to stronger muscles, researchers see intriguing potential for combating age-related decline and osteoporosis.
Ozempic and Wegovy linked to nearly 40% fewer asthma attacks
Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers say GLP-1 drugs may offer respiratory benefits in addition to their effects on diabetes and obesity, but clinical trials are needed to confirm the findings.
Bone marrow myelopoiesis dysfunction in Alzheimer's disease limits monocyte homing to the brain and drives disease progression
Bone marrow-derived macrophages were shown to play an important role in coping with Alzheimer's disease (AD). Boosting their spontaneous recruitment reduces inflammation and disease pathology and slows cognitive decline in mouse models of amyloidosis. However, the factors limiting their spontaneous homing to the diseased brain remain unclear. In this study, we discovered that monocyte development is impaired in mouse models and in patients. In the 5×FAD mouse model, monocyte differentiation was...
The hidden role of the bone marrow in Alzheimer's disease
No abstract
Drug delivery gets subcellular
Nasal vaccines could stop pandemics before they begin
Dose once, treat forever: drugs are being engineered to last much longer
The Einstein test: what happens when AI tries to rediscover relativity?
A good drug is useless if it misses its target
Why we need an International Panel on Inequality
Medicines do no good if people don’t take them
Drug-delivering particles aim to breach the blood–brain barrier
Special delivery: bacterial couriers are smuggling drugs into cancers
These six advances could change how drugs are delivered
Why the super-fun Ig Nobel prizes bring serious value to science
In the basement of miniaturized relics
Bacteria recruited to treat cancer
How AI is changing PhD programmes: join our free webinar
DeepMind’s new genome ‘atlas’ charts effects of all nine billion human gene mutations
Caffeine may flip an ancient cellular switch linked to slower aging
Scientists found that caffeine activates an ancient cellular energy system involved in stress resistance, DNA repair, and growth. The discovery could help explain caffeine’s links to healthier aging and may point toward new ways to target the same pathway.